Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Journal: Nature Medicine

Published: 2018-04-30

DOI: 10.1038/s41591-018-0009-7

Affiliations: 28

Authors: 38

Go to article
Institutions FC
ICR Clinical Trials and Statistics Unit (ICR-CTSU), United Kingdom (UK) 0.16
Breast Cancer Now King's College London Research Unit (BCN-KCL), United Kingdom (UK) 0.09
Myriad Genetics, Inc., United States of America (USA) 0.08
Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) 0.05
King’s Health Partners, United Kingdom (UK) 0.05
Velindre Cancer Centre, Velindre NHS Trust, United Kingdom (UK) 0.05
Department of Surgery and Cancer, ICL, United Kingdom (UK) 0.04
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.03
Division of Cancer Studies, KCL, United Kingdom (UK) 0.03
The Christie NHS Foundation Trust, United Kingdom (UK) 0.03
Health Innovation Manchester, United Kingdom (UK) 0.03
Breast Unit, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.03
Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) 0.03
NIHR University College London Hospitals Biomedical Research Centre, United Kingdom (UK) 0.03
ICR Breast Cancer Now Toby Robins Research Centre, United Kingdom (UK) 0.03
Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) 0.03
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.03
Weston Park Hospital, United Kingdom (UK) 0.03
Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, United Kingdom (UK) 0.03
Department of Clinical Oncology, NUH, United Kingdom (UK) 0.03
Beatson West Of Scotland Cancer Centre (BWoSCC), United Kingdom (UK) 0.03
UNC Department of Genetics, United States of America (USA) 0.03
School of Cancer and Pharmaceutical Sciences, KCL, United Kingdom (UK) 0.01
Protein Phosphorylation Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.01
The Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.01
ICR Division of Molecular Pathology, United Kingdom (UK) 0.01
ICR Division of Genetics and Epidemiology, United Kingdom (UK) 0.01
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.01

Return